The APOE ɛ4 allele modulates brain white matter integrity in healthy adults

The Apolipoprotein E (APOE) ɛ4 allele is the best-established genetic risk factor for sporadic Alzheimer's disease, and is also associated with structural gray matter and functional brain changes in healthy young, middle-aged and elderly subjects. Because APOE is implicated in brain mechanisms associated with white matter (WM) development and repair, we investigated the potential role played by the APOE polymorphism on WM structure in healthy younger (aged 20–35 years) and older (aged 50–78 years) adults using diffusion tensor imaging. General reduction of fractional anisotropy and increase in mean diffusivity values was found in carriers of the APOE ɛ4 allele relative to non-carriers. No significant interactions between genotype and age were observed, suggesting that differences in WM structure between APOE ɛ4-carriers and non-carriers do not undergo significant differential changes with age. This result was not explained by differences in brain morphology or cognitive measures. The APOE ɛ4 allele modulates brain WM structure before any clinical or neurophysiological expression of impending disease.

[1]  P. Matthews,et al.  Distinct patterns of brain activity in young carriers of the APOE e4 allele , 2009, NeuroImage.

[2]  G. Small,et al.  Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[3]  Maria Assunta Rocca,et al.  Voxel-based analysis derived from fractional anisotropy images of white matter volume changes with aging , 2008, NeuroImage.

[4]  A. Dale,et al.  Age-related alterations in white matter microstructure measured by diffusion tensor imaging , 2005, Neurobiology of Aging.

[5]  M. Martini,et al.  Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease , 1999, Neuroscience Letters.

[6]  Jonas Persson,et al.  Reduced functional brain activity response in cognitively intact apolipoprotein E ε4 carriers , 2006 .

[7]  Timothy Edward John Behrens,et al.  Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. , 2007, Brain : a journal of neurology.

[8]  Andrew J. Saykin,et al.  Regional brain atrophy in cognitively intact adults with a single APOE ε4 allele , 2006, Neurology.

[9]  Kaarin J Anstey,et al.  Total and regional gray matter volume is not related to APOE*E4 status in a community sample of middle-aged individuals. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[10]  Peter Boesiger,et al.  Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. , 2007, Cerebral cortex.

[11]  E Brisch,et al.  The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*) , 1995, The Journal of Biological Chemistry.

[12]  Stephen M. Smith,et al.  Bayesian statistical models of shape and appearance for subcortical brain segmentation , 2007 .

[13]  Daniel Bandy,et al.  Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease , 1998, Annals of neurology.

[14]  Jie Xu,et al.  White matter damage of patients with Alzheimer’s disease correlated with the decreased cognitive function , 2006, Surgical and Radiologic Anatomy.

[15]  B. Mazoyer,et al.  Apolipoprotein E Genotype Is Related to Progression of White Matter Lesion Load , 2009, Stroke.

[16]  D. Loewenstein,et al.  Association of White Matter Hyperintensity Measurements on Brain MR Imaging with Cognitive Status, Medial Temporal Atrophy, and Cardiovascular Risk Factors , 2009, American Journal of Neuroradiology.

[17]  H. Soininen,et al.  Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes , 1995, Neuroscience.

[18]  Xianlin Han.  Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer’s disease: a tale of shotgun lipidomics , 2007, Journal of neurochemistry.

[19]  J. Mazziotta,et al.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Jonas Persson,et al.  Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. , 2006, Brain : a journal of neurology.

[21]  A. Dale,et al.  Regional rates of neocortical atrophy from normal aging to early Alzheimer disease , 2009, Neurology.

[22]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[23]  John R Hodges,et al.  The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening , 2006, International journal of geriatric psychiatry.

[24]  D. Head,et al.  Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. , 2004, Cerebral cortex.

[25]  C. Beaulieu,et al.  The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.

[26]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[27]  F. Fazekas,et al.  Apolipoprotein E4allele in the normal elderly: neuropsychologic and brain MRI correlates , 1996, Clinical genetics.

[28]  S. Tsuji,et al.  ApoE-epsilon 4 and early-onset Alzheimer's. , 1994, Nature genetics.

[29]  G. Stebbins,et al.  Diffusion Tensor Imaging in Alzheimer’s Disease and Mild Cognitive Impairment , 2009, Behavioural neurology.

[30]  Usha Sinha,et al.  Exploratory voxel-based analysis of diffusion indices and hemispheric asymmetry in normal aging. , 2007, Magnetic resonance imaging.

[31]  Ichiro Kanazawa,et al.  ApoE–ε4 and early–onset Alzheimer's , 1994, Nature Genetics.

[32]  Andrew J. Saykin,et al.  Increased brain activation during working memory in cognitively intact adults with the APOE ε4 allele , 2006 .

[33]  I. Tesseur,et al.  Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. , 2000, The American journal of pathology.

[34]  R. Honea,et al.  Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. , 2009, Journal of Alzheimer's disease : JAD.

[35]  Thomas E. Nichols,et al.  Anatomically-distinct genetic associations of APOE ɛ4 allele load with regional cortical atrophy in Alzheimer's disease , 2009, NeuroImage.

[36]  I. McKeith,et al.  Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[37]  C. Sudlow,et al.  Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19 000 Subjects , 2009, Stroke.

[38]  H. Braak,et al.  Pattern of brain destruction in Parkinson's and Alzheimer's diseases , 2005, Journal of Neural Transmission.

[39]  P. Basser.  Diffusion MRI: From Quantitative Measurement to In vivo Neuroanatomy , 2009 .

[40]  A. Saykin,et al.  Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. , 2006, The American journal of psychiatry.

[41]  Brian Patenaude,et al.  Bayesian statistical models of shape and appearance for subcortical brain segmentation , 2007 .

[42]  Timothy Edward John Behrens,et al.  Characterization and propagation of uncertainty in diffusion‐weighted MR imaging , 2003, Magnetic resonance in medicine.

[43]  Daniel Rueckert,et al.  Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.

[44]  Andrew J. Saykin,et al.  Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease , 2009, PloS one.

[45]  M. Filippi,et al.  The contribution of voxel-based morphometry in staging patients with mild cognitive impairment , 2006, Neurology.

[46]  R. Kahn,et al.  Functionally linked resting‐state networks reflect the underlying structural connectivity architecture of the human brain , 2009, Human brain mapping.

[47]  Caroline Hayward,et al.  Ageing: Cognitive change and the APOE ɛ4 allele , 2002, Nature.

[48]  H C Charles,et al.  Hippocampal sulcal cavities on MRI: Relationship to age and apolipoprotein E genotype , 2000, Neurology.

[49]  R. Mahley,et al.  Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease , 1995, Current opinion in lipidology.

[50]  Paul M. Thompson,et al.  Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers , 2008, NeuroImage.

[51]  A D Roses,et al.  A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease , 2009, The Pharmacogenomics Journal.

[52]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[53]  N. Schuff,et al.  Age effects on atrophy rates of entorhinal cortex and hippocampus , 2006, Neurobiology of Aging.

[54]  G. Frisoni,et al.  Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease , 1999, Neurology.

[55]  S. Rose,et al.  Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.

[56]  R. Mahley,et al.  Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.

[57]  John J Sidtis,et al.  Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers , 2005, Neuroreport.

[58]  A Hofman,et al.  Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes , 2002, Neurology.

[59]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[60]  L Nyberg,et al.  Altered brain white matter integrity in healthy carriers of the APOE ε4 allele , 2006, Neurology.

[61]  Peter Boesiger,et al.  Better Memory and Neural Efficiency in Young Apolipoprotein E ε4 Carriers , 2007 .

[62]  Sterling C. Johnson,et al.  White matter is altered with parental family history of Alzheimer's disease , 2010, Alzheimer's & Dementia.

[63]  A. Hofman,et al.  Periventricular cerebral white matter lesions predict rate of cognitive decline , 2002, Annals of neurology.

[64]  G J Tsongalis,et al.  Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. , 2006, Neurology.

[65]  G. Murray,et al.  Association of apolipoprotein E polymorphism with outcome after head injury , 1997, The Lancet.

[66]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[67]  Anders H. Andersen,et al.  White matter diffusion alterations in normal women at risk of Alzheimer's disease , 2010, Neurobiology of Aging.

[68]  Yaakov Stern,et al.  fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease , 2005, Neurology.

[69]  Deanna Greenstein,et al.  Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study , 2007, The Lancet Neurology.

[70]  J. Brandt,et al.  APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease , 2008, Neurology.

[71]  Ian J. Deary,et al.  Cognitive change and the APOE epsilon 4 allele. , 2002 .

[72]  Johan H. C. Reiber,et al.  MMSE scores correlate with local ventricular enlargement in the spectrum from cognitively normal to Alzheimer disease , 2008, NeuroImage.

[73]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[74]  Ellen M Wijsman,et al.  Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association. , 2007, Genomics.

[75]  Guojun Bu,et al.  Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy , 2009, Nature Reviews Neuroscience.

[76]  L Nyberg,et al.  Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? , 2006, Neurology.